Crestwood Advisors Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.76M Buy
15,912
+955
+6% +$106K 0.03% 222
2025
Q1
$1.68M Buy
14,957
+460
+3% +$51.5K 0.03% 218
2024
Q4
$1.34M Buy
14,497
+2,321
+19% +$214K 0.03% 218
2024
Q3
$1.02M Buy
12,176
+1,116
+10% +$93.6K 0.02% 231
2024
Q2
$759K Sell
11,060
-5,053
-31% -$347K 0.02% 244
2024
Q1
$1.18M Buy
16,113
+60
+0.4% +$4.4K 0.03% 205
2023
Q4
$1.3M Sell
16,053
-339
-2% -$27.5K 0.03% 191
2023
Q3
$1.23M Buy
+16,392
New +$1.23M 0.03% 179
2021
Q1
Sell
-7,822
Closed -$456K 267
2020
Q4
$456K Sell
7,822
-964
-11% -$56.2K 0.02% 195
2020
Q3
$555K Sell
8,786
-2,611
-23% -$165K 0.02% 162
2020
Q2
$877K Buy
11,397
+129
+1% +$9.93K 0.04% 129
2020
Q1
$842K Sell
11,268
-1,364
-11% -$102K 0.04% 126
2019
Q4
$821K Sell
12,632
-1,271
-9% -$82.6K 0.03% 143
2019
Q3
$881K Sell
13,903
-1,488
-10% -$94.3K 0.04% 137
2019
Q2
$1.04M Buy
+15,391
New +$1.04M 0.05% 130
2017
Q4
Sell
-2,735
Closed -$222K 195
2017
Q3
$222K Buy
2,735
+5
+0.2% +$406 0.02% 139
2017
Q2
$207K Buy
2,730
+279
+11% +$21.2K 0.02% 137
2017
Q1
$168K Sell
2,451
-1,778
-42% -$122K 0.01% 147
2016
Q4
$303K Buy
4,229
+208
+5% +$14.9K 0.03% 120
2016
Q3
$318K Sell
4,021
-157
-4% -$12.4K 0.04% 98
2016
Q2
$349K Sell
4,178
-11,053
-73% -$923K 0.04% 98
2016
Q1
$1.4M Sell
15,231
-1,743
-10% -$160K 0.17% 59
2015
Q4
$1.72M Buy
16,974
+2,906
+21% +$294K 0.21% 57
2015
Q3
$1.38M Sell
14,068
-2,193
-13% -$215K 0.18% 55
2015
Q2
$1.9M Buy
16,261
+10,059
+162% +$1.18M 0.25% 49
2015
Q1
$609K Buy
6,202
+3,291
+113% +$323K 0.09% 73
2014
Q4
$274K Buy
+2,911
New +$274K 0.04% 107